Prescription for Wellness ~ Leveraging Insurance Carrier Resources to Optimize Patient Engagement Outcomes!

Nov. 2025Education/Webinars

Prescription for Wellness is a nationally recognized, Six Sigma-developed best practice system that provides a convenient and effective way for providers to prescribe resources and support offered by UPMC Health Plan to their patients who are UPMC Health Plan members.

Suzanne Labriola, DO, DipACLM, Senior Medical Director, UPMC Employee Group Medical Director, Prescription for Wellness, UPMC Health Plan and Christine Sheffey, MSW, BCBA, Senior Program Manager, Prescription for Wellness, UPMC Health Plan, host a recorded CME-accredited webinar on the topic of Prescription for Wellness- Supercharging Wellness Engagement and Outcomes through Provider Referral.

At the end of this course attendees should be able to:

  • Describe strategies they can deploy to integrate care across payer and provider with the goal of improving population health outcomes and addressing health care disparities.
  • Explain how to utilize quality measures and data analytics to evaluate the impact of provider-prescribed health coaching and care management on patient-member health, self-care for chronic diseases, and shared decision-making.
  • Define best practice processes to promote strategic implementation and optimization of a patient-member engagement platform.

This course can be accessed via this link

If you are a new user of the UPMC Center for Continuing Education in the Health Sciences (CCEHS) website, you can register after clicking on any of the webinars below, or you can register with the CCEHS now.

The Prescription for Wellness (PFW) operational team is available to help you, and your practice integrate PFW into existing office workflows. To get started, contact the PFW team at RxforWellness@upmc.edu.


Recent Announcements

Voluntary nationwide recall: Atorvastatin (Alkem – October)

Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.
Nov. 2025Pharmacy Updates

October 2025 UPMC for You and UPMC Community HealthChoices formulary update

Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.
Oct. 2025Pharmacy Updates

Voluntary nationwide recall: Ocaliva (Intercept – September)

Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).
Oct. 2025Pharmacy Updates